Dr. Barbosa has more than two decades of experience leading drug discovery and development programs at major pharmaceutical and biotechnology companies. Currently, Dr Barbosa is Advisor to several organizations in the health care field. Dr. Barbosa was Global Head and Vice President of Immunology Research and External Innovation at Janssen Research & Development, where he oversaw Immunology Research and new initiatives, including approved drugs STELARA and TREMFYA. In addition, Dr. Barbosa held positions of increasing responsibility managing new drug R&D programs at prominent biopharmaceutical firms, including Centocor, Signal Pharmaceuticals, Chugai Biopharma, TRL USA, Mirna Therapeutics and Assembly Biosciences. Dr. Barbosa received a BS, Genetics degree from the University of California, Davis and a PhD, Microbiology & Immunology from the University of California, Los Angeles. He completed a post-doctoral fellowship at the National Cancer Institute.